loader
Please Wait
Applying Filters...
menu
    • menu

    Drug Product Composition: Irinotecan

    Menu

    Irinotecan

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 21,887Xls

    Filters

    clear-filterReset all filters
    SearchXls

    USFDA APPLICATION NUMBER - 20571 / DOSAGE - INJECTABLE;INJECTION - 100MG/5ML (20MG/ML)

    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    IRINOTECAN HYDROCHLORIDE(UNII: 042LAQ1IIS)
    (IRINOTECAN - UNII:7673326042)     		IRINOTECAN HYDROCHLORIDE20mg in 1

    Inactive Ingredients

    Ingredient Name
    Actavis Pharma, Inc.
    Armas Pharmaceuticals Inc.
    Fresenius Kabi USA, LLC
    Heritage Pharmaceuticals Inc.
    Pharmacia and Upjohn Company LLC
    Sagent Pharmaceuticals
    Sandoz Inc
    Sun Pharma Global FZE
    Teva Parenteral Medicines, Inc.
    Areva Pharmaceuticals,Inc.
    Cipla Limited
    NorthStar RxLLC
    BluePoint Laboratories
    HYDROCHLORIC ACID(QTT17582CB)    
    LACTIC ACID(33X04XA5AT)   
    LACTIC ACID, UNSPECIFIED FORM(33X04XA5AT)          
    SODIUM HYDROXIDE(55X04QC32I)
    SORBITOL(506T60A25R) 
    WATER(059QF0KO0R)